SINUSACIACI3.0/D/C.01.12.03/3kWBERGERLAHRWPM311.004-00WPM311.004-00WPM3110040065032000303BERGERLAHRWD5-008WD5-008.151-00WD5008WD500815100C-283/90645815100031600BERGERLAHRVRDM31122/50LWCEBBERGERLAHRTWINLINETLC534PFSAMTLC534PFSAM0063553490006BERGERLAHRTLC532PFSAMTLC532PFSAMTLC532PFSAM0063553290003BERGERLAHR...
It is important to emphasize that ivabradine is indicated only for patients mainly in sinus rhythm, not in those with persistent or chronic AF, those experiencing 100% atrial pacing, or unstable patients. A history of paroxysmal AF is not a contraindication to ivabradine; in the SHIFT study, ...
The term “permanent AF” is used when the patient and clinician make a joint decision to stop further attempts to restore and/or maintain sinus rhythm. • Acceptance of AF represents a therapeutic attitude on the part of the patient and clinician rather than an inherent pathophysiological attri...
Atrial Tachycardia Arising From the Coronary Sinus Musculature: Electrophysiological Characteristics and Long-Term Outcomes of Radiofrequency Ablation Nitish Badhwar, Jonathan M. Kalman, Paul B. Sparks, Peter M. Kistler, Mehran Attari, Marcie Berger, Randall J. Lee, Jasbir Sra, Melvin M. Scheinman ...
In sinus node reentry tachycardia, a form of focal AT, the P-wave morphology is identical to the P wave in sinus rhythm. 2.4. Principles of Medical Therapy See Figure 8 for the algorithm for acute treatment of tachycardia of unknown mechanism; Figure 9 for the algorithm for ongoing ...
For patients with AF of 48-h duration or longer, or when the duration of AF is unknown, anticoagulation (INR 2.0 to 3.0) is recommended for at least 3 wk prior to and 4 wk after cardioversion, regardless of the method (electrical or pharmacological) used to restore sinus rhythm. (Level...